Queen Mary University of London Jul 17, 2020 BRCA1/2 Population Screening Predicted to be Cost-Effective in Countries With Different Income Levels May 30, 2020 Bavencio Presents Potentially Curative Option for Patients With Rare PD-L1-Expressing Gestational Tumors Oct 8, 2019 ESMO Trial Results Raise Possibility of Neoadjuvant Keytruda Use in Triple-Negative Breast Cancer Premium Oct 3, 2019 Study Finds Breast, Ovarian Cancer Gene Tests Cost-Effective for Unselected Breast Cancer Patients Sep 16, 2019 UK-Led Team Pushes for Broader BRCA Screening Policies With Data on Ashkenazi Population Premium Breaking News European Commission Approves Libtayo in PD-L1-Positive Non-Small Cell Lung Cancer NICE Backs Merck's Keytruda for PD-L1-Expressing Cervical Cancer Genialis Closes $13M Series A Funding Round Breast Cancer Study Leads to New Susceptibility Gene, Potential Treatment Strategies Incyte's Pemazyre Approved in Japan for FGFR1-Positive Rare Blood Cancers Cardiff Oncology Begins Phase II Onvansertib Trial in KRAS-, NRAS-Mutant Colorectal Cancer
